CdmoGen is a gene therapy new drug development company specializing in therapeutics for ocular diseases that is also a full-service CTDMO. The South Korean company offers a comprehensive suite of customizable contract testing, development, and manufacturing services for virus vector–based and mRNA technology–based biopharmaceuticals.